We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+13.26%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$232M
AUM Growth
-$69.4M
Cap. Flow
-$146M
Cap. Flow %
-62.7%
Top 10 Hldgs %
36.64%
Holding
63
New
12
Increased
9
Reduced
17
Closed
25

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$8.51M
2
CTLT
CATALENT, INC.
CTLT
+$7.82M
3
BAX icon
Baxter International
BAX
+$7.15M
4
UHS icon
Universal Health Services
UHS
+$6.95M
5
UNH icon
UnitedHealth
UNH
+$6.76M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$35.6M
2
HUM icon
Humana
HUM
+$19.1M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$15.7M
4
SNN icon
Smith & Nephew
SNN
+$11.6M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.55M

Sector Composition

Rank Sector Weight
1 Healthcare 98.4%
2 Energy 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
51
DELISTED
Hologic
HOLX
– –
-100,000
Closed -$5.7M
ILMN icon
52
Illumina
ILMN
$29.1B
– –
-10,280
Closed -$3.7M
INCY icon
53
Incyte
INCY
$24.5B
– –
-100,000
Closed -$9.29M
ISRG icon
54
Intuitive Surgical
ISRG
$142B
– –
-1,200,000
Closed -$7.24M
NVO
55
Novo Nordisk
NVO
$203B
– –
-420,000
Closed -$7.37M
SNN icon
56
Smith & Nephew
SNN
$12.5B
– –
-120,000
Closed -$11.6M
TEVA icon
57
Teva Pharmaceuticals
TEVA
$42.8B
– –
-275,000
Closed -$3.39M
THC icon
58
Tenet Healthcare
THC
$21.5B
– –
-25,000
Closed -$3.84M
VRTX icon
59
Vertex Pharmaceuticals
VRTX
$133B
– –
-30,000
Closed -$5.63M
NVRO
60
DELISTED
NEVRO CORP.
NVRO
– –
-40,000
Closed -$4.78M
EIGR
61
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-1,467
Closed -$423K
HRC
62
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-80,000
Closed -$9.55M
CNST
63
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-60,000
Closed -$1.8M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q3 2020 Portfolio in Review

As of Q3 2020, Sivik Global Healthcare held 63 positions worth $232M, down 23% from $302M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare withdrew a net $146M in Q3 2020, closing 25 positions and reducing 17 holdings. Its most notable exit was Smith & Nephew, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Eli Lilly worth $8.14M.

  • Sivik Global Healthcare's largest Q3 2020 buy was Eli Lilly: 55,000 shares worth $8.14M.
  • Sivik Global Healthcare added most to Abbott in Q3 2020, an estimated $6.59M increase.
  • Sivik Global Healthcare's biggest Q3 2020 reduction was Thermo Fisher Scientific, cutting an estimated $35.6M.
  • Sivik Global Healthcare fully exited Smith & Nephew in Q3 2020, selling an estimated $11.6M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $232M portfolio in Q3 2020.
  • Sivik Global Healthcare opened 12 new positions and closed 25 in Q3 2020.
  • Sivik Global Healthcare's portfolio value fell 23% quarter-over-quarter to $232M.

Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.